Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$679,626
+$311,714 QoQ
Shares Held
30,600
+5.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#134
of 245 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Derivatives in DYN
reported options exposure · as of Mar 31, 2025CallValue
$626,554
CallShares
59,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. DYN ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
465,787 | $87,232,589 | |
| 2 | ABVX |
Abivax S.A.
|
563,367 | $75,074,286 | |
| 3 | EXEL |
Exelixis, Inc.
|
804,095 | $43,750,808 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
534,163 | $31,050,895 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
692,825 | $26,812,327 | |
| 6 | CGEM |
Cullinan Therapeutics, Inc.
|
1,082,611 | $19,714,346 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
500,497 | $15,645,536 | |
| 8 | AVTX |
Avalo Therapeutics, Inc.
|
702,051 | $12,973,902 |
All Filings in DYN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $679,626 | 30,600 | Shares | Other | 2026-08-14 | |
| 2025-09-30 | $367,912 | 29,084 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,143,199 | 120,084 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,203,715 | 115,078 | Shares | Other | 2025-05-15 | |
| 2025-03-31 | $626,554 | 59,900 | Call | Other | 2025-05-15 | |
| 2024-12-31 | $1,922,496 | 81,600 | Put | Other | 2025-02-14 | |
| 2024-09-30 | $1,393,696 | 38,800 | Put | Other | 2024-11-14 | |
| 2023-12-31 | $887,110 | 66,700 | Put | Other | 2024-02-14 | |
| 2023-12-31 | $760,760 | 57,200 | Shares | Other | 2024-02-14 | |
| 2023-12-31 | $1,936,480 | 145,600 | Call | Other | 2024-02-14 | |
| 2023-09-30 | $491,904 | 54,900 | Call | Other | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||